{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:26:03Z","timestamp":1790267163335,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jfma.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:19:52Z","timestamp":1716293992000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan"],"prefix":"10.1016","volume":"124","author":[{"given":"Mu-Chi","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-5055","authenticated-orcid":false,"given":"Cheng-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-2943","authenticated-orcid":false,"given":"Shen-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-889X","authenticated-orcid":false,"given":"Ya-Chung","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chang","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-9628","authenticated-orcid":false,"given":"Chih-Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7492-4191","authenticated-orcid":false,"given":"Yang-Jen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jfma.2024.05.009_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1440-1754.2007.01215.x","article-title":"High perinatal seroprevalence of cytomegalovirus in northern Taiwan","volume":"44","author":"Chen","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.009_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-guidelines of the American society of transplantation infectious diseases community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/tid.12447","article-title":"It's not too late: a proposal to standardize the terminology of \"late-onset\" cytomegalovirus infection and disease in solid organ transplant recipients","volume":"17","author":"Razonable","year":"2015","journal-title":"Transpl Infect Dis : an official journal of the Transplantation Society"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"9093","key":"10.1016\/j.jfma.2024.05.009_bib7","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet (London, England)"},{"issue":"19","key":"10.1016\/j.jfma.2024.05.009_bib8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International valacyclovir cytomegalovirus prophylaxis transplantation study group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.009_bib9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.009_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/425002","article-title":"The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients","volume":"39","author":"Munoz-Price","year":"2004","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.009_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/rmv.514","article-title":"The case for cytomegalovirus prophylaxis in solid organ transplantation","volume":"16","author":"Snydman","year":"2006","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.009_bib16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1432-2277.2011.01321.x","article-title":"The risk of cytomegalovirus recurrence after kidney transplantation","volume":"24","author":"Helanter\u00e4","year":"2011","journal-title":"Transpl Int : official journal of the European Society for Organ Transplantation"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.009_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.009_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/cid\/cit521","article-title":"Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients","volume":"57","author":"Durand","year":"2013","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13149","article-title":"Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia","volume":"32","author":"Beam","year":"2018","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cix793","article-title":"Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"10.1016\/j.jfma.2024.05.009_bib28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/17512433.2018.1501557","article-title":"Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation","volume":"11","author":"Meesing","year":"2018","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1086\/598952","article-title":"An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants","volume":"199","author":"Manuel","year":"2009","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jfma.2024.05.009_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/infdis\/171.4.1014","article-title":"OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation","volume":"171","author":"Portela","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.009_bib33","doi-asserted-by":"crossref","first-page":"381. e1","DOI":"10.1016\/j.cmi.2018.05.010","article-title":"Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment","volume":"25","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Clin Microbiol Infection"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00041552-199611000-00009","article-title":"Mycophenolate mofetil in kidney transplantation","volume":"5","author":"Lui","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib35","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1600-6143.2011.03724.x","article-title":"Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation","volume":"11","author":"Gala-Lopez","year":"2011","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib36","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13483","article-title":"Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: a systematic literature review of real-world evidence","volume":"23","author":"Raval","year":"2021","journal-title":"Transpl Infect Dis : an official journal of the Transplantation Society"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib38","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2011.03674.x","article-title":"Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials","volume":"11","author":"Brennan","year":"2011","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib39","first-page":"361","article-title":"Use of everolimus-based immunosuppression to decrease cytomegalovirus infection after kidney transplant","volume":"14","author":"Malvezzi","year":"2016","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transpl Infect Dis : an official journal of the Transplantation Society"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial","volume":"75","author":"Avery","year":"2022","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"25","key":"10.1016\/j.jfma.2024.05.009_bib43","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2023.9106","article-title":"Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial","volume":"330","author":"Limaye","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.009_bib45","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/j.1600-6143.2012.04231.x","article-title":"Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial","volume":"12","author":"Winston","year":"2012","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.jfma.2024.05.009_bib46","unstructured":"\u8ca1\u5718\u6cd5\u4eba\u5668\u5b98\u6350\u8d08\u79fb\u690d\u767b\u9304\u53ca\u75c5\u4eba\u81ea\u4e3b\u63a8\u5ee3\u4e2d\u5fc3. \u6b77\u5e74\u5404\u5668\u5b98\u7d44\u7e54\u53d7\u8d08\u4eba\u6578\u7d71\u8a08. (https:\/\/www.torsc.org.tw\/statistics\/statistics_01.jsp)."},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.transproceed.2013.11.115","article-title":"Universal valganciclovir prophylaxis significantly reduces episodes of first-year cytomegalovirus disease and biopsy-proven acute rejection in kidney transplant recipients","volume":"46","author":"Tu","year":"2014","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.jfma.2024.05.009_bib48","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.transproceed.2008.07.105","article-title":"Risk factors among donor characteristics which affect graft outcome in paired kidney transplantation","volume":"40","author":"Tian","year":"2008","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.jfma.2024.05.009_bib49","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.transproceed.2018.01.023","article-title":"Effect of low-dose vs standard-dose valganciclovir in the prevention of cytomegalovirus disease in kidney transplantation recipients: a systemic review and meta-analysis","volume":"50","author":"Hwang","year":"2018","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1253\/circj.71.968","article-title":"Correlation between body mass index and leucopenia after administration of valganciclovir for cytomegalovirus infection in Chinese cardiac recipients","volume":"71","author":"Chen","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jfma.2024.05.009_bib51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s12879-014-0569-1","article-title":"Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children","volume":"14","author":"Cannon","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/AEM.03262-13","article-title":"Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands","volume":"80","author":"Stowell","year":"2014","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12879-018-3318-z","article-title":"CMV on surfaces in homes with young children: results of PCR and viral culture testing","volume":"18","author":"Amin","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/TP.0b013e318200b9f0","article-title":"Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients","volume":"91","author":"Boillat Blanco","year":"2011","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.009_bib55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/TP.0b013e31822fa4b7","article-title":"Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients","volume":"92","author":"Lisboa","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.009_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/TP.0b013e3181bc0301","article-title":"Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance","volume":"89","author":"van der Beek","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.009_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/342601","article-title":"Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease","volume":"186","author":"Humar","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/315242","article-title":"Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation","volume":"181","author":"Sia","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/TP.0000000000000386","article-title":"The role of secondary cytomegalovirus prophylaxis for kidney and liver transplant recipients","volume":"99","author":"Sullivan","year":"2015","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib60","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/cid\/cix696","article-title":"Role of secondary prophylaxis with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"65","author":"Gardiner","year":"2017","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.009_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","article-title":"New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant\/refractory disease","volume":"12","author":"Kotton","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.009_bib63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl Infect Dis : an official journal of the Transplantation Society"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib64","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(02)00463-1","article-title":"Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients","volume":"21","author":"Bhorade","year":"2002","journal-title":"J Heart Lung Transplant : the official publication of the International Society for Heart Transplantation"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.009_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-0012.2007.00761.x","article-title":"Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes","volume":"22","author":"Eid","year":"2008","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.009_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-3062.2002.t01-1-02008.x","article-title":"Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection","volume":"4","author":"Isada","year":"2002","journal-title":"Transpl Infect Dis : an official journal of the Transplantation Society"},{"key":"10.1016\/j.jfma.2024.05.009_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10332","article-title":"Cytomegalovirus management in solid organ transplant recipients: a pre-COVID-19 survey from the working group of the European society for organ transplantation","volume":"35","author":"Grossi","year":"2022","journal-title":"Transpl Int : official journal of the European Society for Organ Transplantation"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.009_bib68","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis","volume":"94","author":"Andrassy","year":"2012","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jfma.2024.05.009_bib69","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11255-014-0783-1","article-title":"Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis","volume":"46","author":"Su","year":"2014","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"10.1016\/j.jfma.2024.05.009_bib70","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/ajt.13327","article-title":"Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses","volume":"15","author":"Tedesco-Silva","year":"2015","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T20:36:09Z","timestamp":1740429369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0929664624002456"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.05.009","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}